Cargando…
Intravesical chemotherapy synergize with an immune adjuvant by a thermo-sensitive hydrogel system for bladder cancer
Surgical resection remains the prefer option for bladder cancer treatment. However, the effectiveness of surgery is usually limited for the high recurrence rate and poor prognosis. Consequently, intravesical chemotherapy synergize with immunotherapy in situ is an attractive way to improve therapeuti...
Autores principales: | Liu, J., Yang, T.Y., Dai, L.Q., Shi, K., Hao, Y., Chu, B.Y., Hu, D.R., Bei, Z.W., Yuan, L.P., Pan, M., Qian, Z.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10468327/ https://www.ncbi.nlm.nih.gov/pubmed/37663619 http://dx.doi.org/10.1016/j.bioactmat.2023.08.013 |
Ejemplares similares
-
Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel
por: Yoon, Ho Yub, et al.
Publicado: (2019) -
MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes
por: Zhang, Z.W., et al.
Publicado: (2017) -
Intravesical chemotherapy for intermediate risk non-muscle invasive bladder cancer recurring after a first cycle of intravesical adjuvant therapy
por: Serretta, Vincenzo, et al.
Publicado: (2015) -
Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
por: Magalhães, Joana C, et al.
Publicado: (2023) -
Intravesical chemotherapy in non-muscle-invasive bladder cancer
por: Porten, Sima P., et al.
Publicado: (2015)